Clearpoint Neuro (NASDAQ:CLPT) specializes in providing innovative technology and services for the treatment of various neurological disorders. This company focuses on the development and commercialization of navigation and delivery technologies to allow for minimally invasive surgeries within the brain. With projects ranging from surgical navigation systems to therapy delivery platforms, Clearpoint Neuro aims to improve the precision and safety of neurosurgical procedures. Their objectives include expanding their technology's use to support biologics and drug delivery, as well as fostering collaborations with leading institutions and companies to propel advancements in neurosurgery. Clearpoint Neuro is dedicated to transforming how neurological disorders are treated, enhancing patient outcomes and advancing the field of neurosurgery.